Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
International Journal of Cancer|January 18, 2020
Immune checkpoint inhibitors in advanced nasopharyngeal carcinoma: Beyond an era of chemoradiation?Liam Masterson, James Howard, Jazmina Gonzalez-Cruz, et al.
JAMA Otolaryngology-- Head & Neck Surgery|April 10, 2025
Development, Validation, and Valuation of a Head and Neck Cancer-Specific Health Utility Instrument (HNC-8D): A Head and Neck Cancer International Group Collaborative StudyJohn R de Almeida, Jie Su, Abdullah AlShenaiber, et al.
Acta Oncologica (Stockholm, Sweden)|February 10, 2022
International assessment of interobserver reproducibility of flap delineation in head and neck carcinomaArnaud Beddok, Leslie Guzene, Alexandre Coutte, et al.
Oral Oncology|December 15, 2023
Clinical decision pathway and management of locally advanced head and neck squamous cell carcinoma: A multidisciplinary consensus in Asia-PacificYe Guo, Torahiko Nakashima, Byoung Chul Cho, et al.
Head & Neck|September 12, 2020
Evaluating compliance with process-related quality metrics and survival in oral cavity squamous cell carcinoma: Multi-institutional oral cavity collaboration studySara W Liu, Neil M Woody, Wei Wei, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|November 29, 2017
Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelinesVincent Grégoire, Mererid Evans, Quynh-Thu Le, et al.
International Journal of Radiation Oncology, Biology, Physics|April 18, 2020
Practice Recommendations for Risk-Adapted Head and Neck Cancer Radiation Therapy During the COVID-19 Pandemic: An ASTRO-ESTRO Consensus StatementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|July 31, 2020
Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: An ASTRO-ESTRO consensus statementDavid J Thomson, David Palma, Matthias Guckenberger, et al.
Cancer Causes & Control : CCC|March 11, 2021
The hidden curve behind COVID-19 outbreak: the impact of delay in treatment initiation in cancer patients and how to mitigate the additional risk of dying-the head and neck cancer modelLeandro L Matos, Carlos Henrique Q Forster, Gustavo N Marta, et al.
The New England Journal of Medicine|June 2, 2025
Adjuvant Cemiplimab or Placebo in High-Risk Cutaneous Squamous-Cell CarcinomaDanny Rischin, Sandro Porceddu, Fiona Day, et al.
Pageof 8